Risk of hepatocellular carcinoma in patients with chronic hepatitis C who achieve sustained virologic response with interferon-free versus interferon-based therapy in Japan

Miyase Shiho; Kugiyama Aya; Tsukano Natsumi; Iwashita Hirofumi; Fujiyama Shigetoshi

首页> 外文期刊>Hepatology: Official Journal of the American Association for the Study of Liver Diseases >Risk of hepatocellular carcinoma in patients with chronic hepatitis C who achieve sustained virologic response with interferon-free versus interferon-based therapy in Japan

【24h】

Risk of hepatocellular carcinoma in patients with chronic hepatitis C who achieve sustained virologic response with interferon-free versus interferon-based therapy in Japan

机译：慢性丙型肝炎患者肝细胞癌的风险，慢性丙型肝炎患者在日本无干扰素与干扰素的疗法持续的病毒性反应

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Hepatology: Official Journal of the American Association for the Study of Liver Diseases》 |2017年第1期|共1页
作者
Miyase Shiho; Kugiyama Aya; Tsukano Natsumi; Iwashita Hirofumi; Fujiyama Shigetoshi;
展开▼
作者单位

Kumamoto Shinto Gen Hosp Dept Gastroenterol &

Hepatol Kumamoto Japan;

Kumamoto Shinto Gen Hosp Dept Gastroenterol &

Hepatol Kumamoto Japan;

Kumamoto Shinto Gen Hosp Dept Gastroenterol &

Hepatol Kumamoto Japan;

Kumamoto Shinto Gen Hosp Dept Gastroenterol &

Hepatol Kumamoto Japan;

Kumamoto Shinto Gen Hosp Dept Gastroenterol &

Hepatol Kumamoto Japan;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类消化系及腹部疾病;
关键词

相似文献

外文文献
中文文献
专利

1. Risk of hepatocellular carcinoma in patients with chronic hepatitis C who achieve sustained virologic response with interferon-free versus interferon-based therapy in Japan [J] . Miyase Shiho, Kugiyama Aya, Tsukano Natsumi, Hepatology: Official Journal of the American Association for the Study of Liver Diseases . 2017,第Suppla1期

机译：慢性丙型肝炎患者肝细胞癌的风险，慢性丙型肝炎患者在日本无干扰素与干扰素的疗法持续的病毒性反应
2. Higher levels of AFP, AFP-L3, and PIVKA-II in hepatocellular carcinoma recurrence in patients with chronic hepatitis C who achieved sustained virologic response with interferon-free compared with interferon-based therapy [J] . Miyase Shiho, Kugiyama Aya, Tsukano Natsumi, Hepatology: Official Journal of the American Association for the Study of Liver Diseases . 2017,第Suppla1期

机译：慢性丙型肝炎患者的肝细胞癌复发中患者患有慢性丙型肝炎患者的肝细胞癌复发水平更高水平的AFP，AFP-L3和PIVKA-II与干扰素的无干扰素的疗法相比
3. Differences in background characteristics of patients with chronic hepatitis C who achieved sustained virologic response with interferon‐free versus interferon‐based therapy and the risk of developing hepatocellular carcinoma after eradication of hepatitis C virus in Japan [J] . Toyoda H., Tada T., Takaguchi K., Journal of viral hepatitis. . 2017,第6期

机译：慢性丙型肝炎患者患者背景特征的差异，从而达到无干扰素与干扰素的治疗和在日本消除丙型肝炎病毒后发育肝细胞癌的风险
4. Betatrophin Expression in Chronic Hepatitis C Patients: Does Contribute to Liver Injury-linked Metabolic Syndrome and Hepatocellular Carcinoma Development? [C] . Hendra Susanto, Nan-Shan Liou, Bogi Pratomo, International Conference on Life Sciences and Technology . 2020

机译：慢性丙型肝炎患者的BERATROPHIN表达：是否有助于肝损伤链接代谢综合征和肝细胞癌发育？
5. Baseline Toronto HCC Risk Index (THRI) and Albumin Predict Low Risk of Hepatocellular Carcinoma (HCC) after Sustained Virological Response (SVR) in HCV Infection [D] . Lau, Jason. 2019

机译：基线多伦多HCC风险指数（THRI）和白蛋白预测HCV感染持续病毒响应（SVR）后肝细胞癌（HCC）的低风险
6. Dynamic noninvasive markers predict hepatocellular carcinoma in chronic hepatitis C patients without sustained virological response after interferon-based therapy [O] . Chao-Min Huang, Tsung-Hui Hu, Kuo-Chin Chang, -1

机译：动态无创标记物可预测慢性丙型肝炎患者的肝细胞癌基于干扰素的治疗后无持续的病毒学应答
7. Obesity and recurrence-free survival in patients with hepatocellular carcinoma after achieving sustained virological response to interferon therapy for chronic hepatitis C [O] . Hiroji Shinkawa, Shogo Tanaka, Shigekazu Takemura, 2018

机译：患有肝细胞癌患者对慢性丙型肝炎的干扰素治疗持续的病毒疗法后患者肥胖和复发的存活

Risk of hepatocellular carcinoma in patients with chronic hepatitis C who achieve sustained virologic response with interferon-free versus interferon-based therapy in Japan

著录项

相似文献

相关主题

期刊订阅